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INTRODUCTION
          Peripheral nerve block, in which local Anaesthetic is injected into a peripheral 
nerve, may provide superior pain relief when used as part of a balanced analgesia
 Femoral nerve block is a basic nerve block technique that is easy to master, carries 
a  low risk  of  complications  and  has  a  significant  clinical  applicability  for  surgical 
anesthesia and postoperative pain management1. 
This block is well suited for postoperative pain management after femur and knee 
surgery& surgical anesthesia of quadriceps muscle biopsy, knee arthroscopy, quadriceps 
tendon repair1.
 
 When combined with the block of the sciatic nerve, anesthesia of the almost entire 
lower extremity from the mid-thigh level can be achieved.
 The success rate of this block for surgery is very high, nearing 95%, as long as 
the scope of surgery does not extend beyond the area of coverage of the femoral nerve.
By placing a catheter into the femoral nerve sheath continuous 3-in-1 nerve block 
is achieved. In addition to femoral nerve obturator nerve and lateral cutaneous nerve of 
the thigh are also blocked1.  
AIM
 A  CONTROLLED  STUDY  TO  COMPARE  THE  EFFICACY  AND  THE 
INCIDENCE OF COMPLICATIONS BETWEEN CONTINUOUS FEMORAL 3 IN 1 
NERVE  BLOCK  AND  CONTINUOUS  EPIDURAL  ANALGESIA  FOR  POST-
OPERATIVE PAIN RELIEF IN FRACTURE NECK OF FEMUR.
REGIONAL ANESTHESIA ANATOMY
FEMORAL NERVE  
 The largest branch of the lumbar plexus, arises from the ventral divisions of the 
second,  third,  and fourth  lumbar nerves.  It  descends through the fibers of  the  Psoas 
major, emerging from the muscle at the lower part of its lateral border, and passes down 
between it  and the  Iliacus,  behind the  iliac  fascia;  it  then runs beneath the  inguinal 
ligament, into the thigh, and splits into an anterior and a posterior division3. 
ANTERIOR DIVISION
Cutaneous Branches: 
1) Intermediate cutaneous nerve 
2) Medial cutaneous nerve.
Muscular Branches (rami musculares)
1) The nerve to the Pectineus 
2) The nerve to the Sartorius 
POSTERIOR DIVISION
Cutaneous Branches
1) The saphenous nerve-largest cutaneous branch of the femoral nerve3.
Muscular Branches 
1) Nerve  to  the  Rectus  femoris enters  the  upper  part  of  the  deep  surface  of  the 
muscle, and also supplies a filament to the hip-joint.
2) The branch to the  Vastus lateralis, it gives off an articular filament to the knee-
joint.
3) The branch to the Vastus medialis. It gives off a filament, which can usually be 
traced downward, on the surface of the muscle, to the knee-joint.
4) The branches to the  Vastus intermedius. A filament from one of these descends 
through the muscle to the Articularis genu and the knee-joint.
NERVE SUPPLY OF THE HIP JOINT4
 The nerve supply to the hip joint is through the femoral nerve and is supplied by 
the following nerves  
(a) The nerve to rectus femoris
(b) The anterior division of the obturator nerve (l2, l3, l4)
(c) The accessory obturator nerve (L3, L4), a small branch from the sciatic nerve also 
supplies the posterior part of the joint through the nerve to quadratus femoris (L4, 
L5, S1).
Anatomy of the Epidural Space 
(i) It is a potential space that lies between the dura and the periosteum lining the 
inside of the vertebral canal.
(ii) It extends from the foramen magnum to the sacral hiatus.
(iii) The anterior  and posterior  nerve roots  in  their  dural  covering pass across this 
potential space to unite in the intervertebral foramen to form segmental nerves. 
(iv) The anterior border consists of the posterior longitudinal ligament covering the 
vertebral bodies and the intervertebral discs.
(v) Laterally,  the  epidural  space  is  bordered  by  the  periosteum  of  the  vertebral 
pedicles and the intervertebral foraminae.
(vi) Posteriorly, the bordering structures are the periosteum of the anterior surface of 
the laminae and articular processes and their connecting ligaments, the periosteum 
of the root of the spines, and the interlaminar spaces filled by the ligamentum 
flavum.
(vii) The space contains venous plexuses and fatty tissue, which is continuous with the 
fat in the paravertebral space. 
Epidural Space 
CONTINUOUS FEMORAL 3 IN 1 NERVE BLOCK
1. POSITION
The patient is in the supine position with both legs extended5.
In obese patients, a pillow placed underneath patient's hips
2. PREMEDICATION
Midazolam and Fentanyl may be given
Deeper sedation is neither recommended nor necessary for this block.
3. LANDMARKS
 Based on the relationships in the Femoral Triangle.
(a) Surface Landmarks 
(i) Inguinal crease
(ii) Femoral artery
       FEMORAL    
       TRIANGLE
(b) Anatomic Landmarks 
(i) Inguinal crease
(ii) Femoral artery pulse
(iii) Needle insertion site is labeled immediately lateral to the pulse of the 
femoral artery. 
Femoral nerve
Femoral artery
Femoral Vein
4. TECHNIQUE
* Cleaning with an antiseptic solution,
* Local anesthetic is infiltrated subcutaneously at the estimated site of needle 
insertion. The injection for the skin anesthesia should be shallow and in a 
line extending laterally to allow for more lateral needle reinsertion when 
necessary
* The anesthesiologist is standing on the side of the patient with the palpating 
hand on the femoral artery.
* The needle is introduced immediately at the lateral border of the artery and 
advanced in the saggital and slightly cephalad plane
Technique Details Specific to Continuous Block Technique5, 1
Insertion of the needle at a slightly more acute angle is necessary to facilitate 
threading of the catheter.
A 5 cm needle  connected to the nerve stimulator  (1.0 mA, 2 Hz, 100µsec) is 
inserted and advanced at a 45-60º cephalad.
Care should be taken to avoid medial insertion of the needle and the consequent 
puncture of the femoral artery.
 After the quadriceps muscle twitch is obtained (patella twitch) at              0.5 mA,  
the initial bolus of local anesthetic is injected (15-20ML)
 The catheter is inserted 5-10 cm beyond the tip of the needle. The catheter is then 
secured to the skin using a clear dressing 
Continuous Infusion
* Diluted bupivacaine or l-bupivacaine (0.25%) are suitable, but may result in more 
motor blockade
* The infusion is maintained at 8 ml/hr or 5 ml/hr when a PCA dose is planned (5 
ml) 
PHARMACOLOGY OF BUPIVACAINE
STRUCTURE
 Bupivacaine Hydrochloride is 2-Piperidinecarboxamide, 1-butyl-N-(2, 6-
dimethylphenyl)-, monohydrochloride, monohydrate2.  
 Bupivacaine  Hydrochloride  Injection  is  available  in  sterile,  isotonic  solutions 
containing Bupivacaine hydrochloride in water for injection. It is an amide type of local  
anesthetic
Bupivacaine Hydrochloride Injection
Concentration
Bupivacaine 
Hydrochloride
mg/mL
Sodium Chloride
mg/mL
0.25% 2.5 8.6
0.50% 5 8.1
0.75% 7.5 7.6
May contain sodium hydroxide or hydrochloric acid for pH adjustment. Multiple-
dose vials contain methylparaben 1 mg/mL added as a preservative.
* Single-dose solutions contain no added bacteriostat or anti-microbial agent and 
unused portions should be discarded after use.
BUPIVACAINE - CLINICAL PHARMACOLOGY6
* Local  anesthetics acts by blocking the generation and the conduction of nerve 
impulses.
(i) by increasing the threshold for electrical excitation in the nerve
(ii) by slowing the propagation of the nerve impulse
(iii) by reducing the rate of rise of the action potential
* The progression of anesthesia is related to
(i) The diameter, myelination of nerve fibres
(ii) Conduction velocity of affected nerve fibers. 
ADVERSE EFFECTS6
1) CVS 
Depress cardiac conduction and excitability - which may lead to atrioventricular 
block, ventricular arrhythmias, and cardiac arrest
In addition,  myocardial  contractility  is  depressed and peripheral  vasodilatation 
occurs, leading to decreased cardiac output and arterial blood pressure.
2) CNS –
Central nervous system stimulation and depression are produced.
Apparent central stimulation is manifested as restlessness, tremors and shivering 
progressing  to  convulsions,  followed  by  depression  and  coma  progressing 
ultimately to respiratory arrest. 
A primary depressant effect may occur on the medulla and on higher centers. This 
depressed stage may occur without a prior excited state.
The rate of systemic absorption of local anesthetics is dependent
* Upon the total dose injected
* Concentration of drug administered,
* The route of administration, the vascularity of the administration site, 
The action of Bupivacaine Hydrochloride is long lasting. It has also been noted 
that there is a period of analgesia that persists after the return of sensation, during which 
the need for strong analgesics is reduced.
DISTRIBUTION
 Pharmacokinetic studies on the plasma profile of Bupivacaine Hydrochloride after 
direct intravenous injection suggest a three-compartment open model.
* The first compartment is represented by the rapid intravascular distribution of the 
drug.
* The second compartment represents the equilibration of the drug throughout the 
highly perfused organs such as the brain, myocardium, lungs, kidneys, and liver. 
* The  third  compartment  represents  an  equilibration  of  the  drug  with  poorly 
perfused tissues, such as muscle and fat.
ELIMINATION
(i) After administration in man, peak levels of Bupivacaine in the blood are reached 
in 30 to 45 minutes, followed by a decline to insignificant levels during the next 
three to six hours.
(ii) The half-life of Bupivacaine Hydrochloride in adults is 2.7 hours and in neonates 
8.1 hours.
(iii) In clinical studies, elderly patients reached the maximal spread of analgesia and 
maximal motor blockade more rapidly than younger patients. Elderly patients also 
exhibited  higher  peak  plasma  concentrations  following  administration  of  this 
BUPIVACAINE. The total plasma clearance was decreased in these patients.
(iv) Bupivacaine Hydrochloride is metabolized primarily in the liver via conjugation 
with  glucuronic  acid.  Patients  with  severe  hepatic  disease  may  be  more 
susceptible  to  the  potential  toxicities  of  the  amide-type  local  anesthetics. 
Pipecoloxylidine is the major metabolite of Bupivacaine Hydrochloride.
(v) The metabolites are excreted primarily in the urine. Only 6% of Bupivacaine is 
excreted unchanged in the urine.
                       
EPIDURAL ANESTHESIA5
INTRODUCTION
The epidural space was first described by Corning in 1901
Fidel Pages first used epidural anaesthesia in humans in 1921. 
In 1945 Tuohy introduced the needle which is used for epidural anaesthesia. 
INDICATIONS
(i) Sole anaesthetic for procedures involving the lower limbs, pelvis, perineum and 
lower abdomen.
(ii) It is possible to perform upper abdominal and thoracic procedures under epidural 
anaesthesia alone. 
(iii) Postoperative analgesia
CONTRAINDICATIONS
Absolute
* Patient refusal
* Coagulopathy
* Therapeutic anticoagulation
* Skin infection at injection site.
* Raised intracranial pressure.
Relative
* Uncooperative patients
* Pre-existing  neurological  disorders,  such  as  multiple  sclerosis.  Maybe  a 
contraindication, because any new neurological symptoms may be ascribed to the 
Epidural.
* Fixed cardiac output states. This includes aortic stenosis. Hypertrophic obstructive 
cardiomyopathy (HOCM), Mitral stenosis and complete heart block.      
* Anatomical  abnormalities  of  vertebral  column may make the placement  of  an 
epidural technically impossible.
* Prophylactic low dose heparin 
TECHNIQUE OF EPIDURAL ANAESTHESIA
Preparation
1. An  epidural  must  be  performed  in  a  work  area  that  is  equipped  for  airway 
management and resuscitation.
2. Facilities for monitoring.
3. Obtain informed consent.
4. Pre-anaesthetic assessment 
5. The back should be draped in a sterile fashion, and the operator should take full 
sterile precautions.
Equipment
1. The epidural needle is typically 16-18G, 8cm long with surface markings at 1cm 
intervals, and has a blunt bevel with a 15-30 degree curve at the tip is called the 
Tuohy needle, and the tip is referred to as the Huber tip.
2. Traditionally, a glass syringe with a plunger, which slides very easily, has been 
used to identify the epidural space.
3. But  currently  most  practitioners  use  a  plastic  syringe  to  identify  a  loss  of 
resistance when pressure is applied to the plunger. Some use saline in the syringe, 
and others use air. 
Midline approach 
 Using local anaesthetic raise a subcutaneous wheal at the midpoint   between two 
adjacent vertebrae  
* Insert  epidural  needle  into  the  skin  at  this  point,  and  advance  through  the 
supraspinous ligament, with the needle pointing in a slightly cephalad direction, 
advance the needle into the interspinous ligament, which is encountered at a depth 
of 2-3 cm.
* With 5-10ml of air in the syringe, attach it to the hub of the needle once it has 
entered the interspinous ligament.  Grip both wings of  the needle  between the 
thumb and forefinger of both hands. The plunger is gently pressed, and if there is 
resistance ("bounce"), the needle is very carefully advanced, with the dorsum of 
both hands resting against the back to provide stability. After 2-3mm, the plunger 
is again gently pressed, and this procedure is repeated as the needle is carefully 
advanced  through  the  tissues.  The  distinctive  increase  in  resistance  when  the 
needle enters the ligamentum flavum is felt, and the process is continued in 2mm 
increments.  There  is  usually  a  distinctive  "click"  when  the  needle  enters  the 
epidural space, at this point air can be injected into the epidural space very easily. 
Remove the syringe and thread the catheter gently via the needle into the epidural 
space. The catheter has markings showing the distance from its tip, and should be 
advanced to 15-18cm at the hub of the needle, to ensure that a sufficient length of 
catheter has entered the epidural space. 
* Remove the needle carefully, ensuring that the catheter is not drawn back with it.  
The markings on the needle will show the depth of the needle from the skin to the 
epidural space, and this distance will help to determine the depth to which the 
catheter should be inserted at the skin
* The catheter fixed under sterile plasters.
The order of nerve fiber block: 
1. Sympathetic – Vasomotor fiber
2. Cold sensation – Feeling of warmth
3. Temperature in discrimination 
4. Slow pain 
5. Fast pain
6. Tactile sense 
7. Motor paralysis 
8. Pressure sense
9. Proprioception
Factors Affecting Epidural Anaesthesia
1. Site of injection
2. Dosage
3. Age, height & weight
4. Posture
5. Gravity 
6. Vasoconstrictors
7. Alkalinisation of local anaesthetics
Physiological Effects of Epidural Blockade
* Cardiovascular system. Hypotension, Bradycardia Cardiac arrest
* Respiratory  system. Unaffected,  unless  blockade  is  high  enough  to  affect 
intercostal muscle nerve supply 
* Gastrointestinal system - predominance of parasympathetic (vagus and sacral 
parasympathetic outflow), leading to active peristalsis and relaxed sphincters, and 
a small, contracted gut, which enhances surgical access. 
* Endocrine system. Nerve supply to the adrenals is blocked leading to a reduction 
in the release of catecholamines.
* Genitourinary  tract. Urinary  retention  is  a  common  problem  with  epidural 
anaesthesia. A severe drop in blood pressure may affect glomerular filtration in 
the kidney if sympathetic blockade extending high enough to cause significant 
vasodilatation.
Complications and Side Effects
Serious  complications  may  occur  with  epidural  anaesthesia.  Facilities  for 
resuscitation should always be available whenever epidural anaesthesia is performed. 
They include:
1.  Sheering of nerve roots 6.  Urinary retention
2.  Hypotension 7.  Infection 
3.  Inadvertent high epidural block 8.  Accidental dural puncture
4.  Local anaesthetic toxicity 9.  Epidural haematoma 
5.  Total spinal 10.Back ache
VISUAL ANALOGUE SCORE7
Pain
 An  unpleasant  sensory  and  emotional  experience  associated  with  actual  or 
potential tissue damage, or described in terms of such damage. There are various scores 
and scales to measure pain.  The commonly used in studies is the visual analogue scale.
 A Visual Analogue Scale (VAS) is a measurement instrument that tries to measure 
a characteristic or attitude that is believed to range across a continuum of values and 
cannot easily be directly measured. From the patient's perspective this spectrum appears 
continuous. Their pain does not take discrete jumps, as a categorization of none, mild, 
moderate and severe 
 Operationally a VAS is usually a horizontal line, 100 mm in length, anchored by 
word descriptors at each end.  The patient marks on the line the point that  they feel 
represents their perception of their current state.
 The VAS score is determined by measuring in millimeters from the left hand end 
of the line to the point that the patient marks.
 There are many other ways in which VAS have been presented, including vertical 
lines and lines with extra descriptors. 
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12 ) Stevens RD, Van Gessel E,  Flory N et al.,  Anesthesiology 2000; 93: 115-121. 14 
Lumbar  plexus  block  reduces  pain  and  blood  loss  associated  with  total  hip 
arthroplasty20.
13) Fletcher AK, Rigby AS, Heyes FL., Ann Emerg Med. 2003 Feb; 41:227 -33.. 3-in-
1 Femoral Nerve Block Provided Fast Pain Relief for Femoral Neck Fracture. 
Three-in-One Femoral Nerve Block as Analgesia for Fractured Neck of Femur in 
the Emergency Department: A Randomized, controlled trial21.
14) Christopher E. Mutty, MD1, Erik J. Jensen, MD2, Michael A. Manka, Jr., MD2,  
Mark J. Anders, MD2 and Lawrence B. Bone, MD2, The Journal of Bone and Joint 
Surgery  (American).  2008;  90:218-226.  Compared  Femoral  Nerve  Block  for 
Diaphyseal  and Distal  Femoral  Fractures  in  the Emergency  Department  in  54 
patients. The  acute  pain  of  a  diaphyseal  or  distal  femoral fracture  can  be 
significantly decreased through the use of a femoral nerve block, which can be 
administered safely in the hospital emergency22.
15) Continuous but not Single-dose Femoral Nerve Sheath Block provides efficient 
Pain relief after Total Hip Replacement (THR). 
(i) Fournier R. et al. Can J Anaesth 45:34-8, 1998, Boujlel, S.1; Delbos, A.2; 
Singelyn,  F.J.1  1.  Anesthesiology,  Universite´  Catholique  de  Louvain 
School of Medicine - Cliniques Universitaires St Luc, Brussels, Belgium23;
(ii) Anesthesiology, Clinique des Ce` dres, Cornebarrieu, France Postoperative 
pain after THR can be difficult to control. Anterior lumbar plexus blockade 
is  efficient  to  treat  such  IV PCA with  morphine.  It  would  thus  be  the 
recommended analgesic technique after THR.
16)    Agri,  20:1,2008   Suleyman koroglu et  al studied the effects  of  pre operative 
continuous femoral 3 in 1 nerve block for THR  on post operative pain relief and 
Tramadol consumption during patient controlled analgesia in 30 patients, it was 
concluded that the 3 in 1 nerve block provided effective post operative pain relief 
for THR reducing post operative analgesic requirements with out increase in side 
effects24.
MATERIALS & METHODS
1. Sixty  patients  of  ASA  physical  status  1&  2  undergoing  elective  ORIF 
(hemiarthroplasty or DHS) for NECK OF FEMUR fracture were included in the 
study
2. All the patients were males and belong to age group of 20-70
3. It  is  a  randomized  controlled  study.  The  study  was  approved  by  institutional 
ethical committee and consent was obtained from the patients
Inclusion criteria8
1. Patients with neck of femur fracture alone
2. Patient ability to give consent and willingness to participate in the study
3. ASA 1-2 category
4. Men in the age group 20-70
Exclusion Criteria1, 8 
1. Inability to give consent for language or cognitive reasons
2. Patient refusal
3. Contra indication to femoral nerve block (infection overlying the injection site or 
previous femoro popliteal by pass surgery)
4. Contra indication to central neuraxial blockade (patient refusal, plate let count less 
than 1 Lakh)
5. Failure of Technique
6.      Duration more than 2 hours
Materials1 
1. Sterile standard anesthesia tray prepared with the following equipments
2. Sterile towels and 4×4 gauze packs
3. Three 20 ml syringe
4. Local anesthetics 0.25% bupivacaine and 2% lignocaine
5. Sterile gloves marking pen, surface electrode
6. One 2 cc 25 gauge needle for skin infiltration
7. A 5-8cm long, short bevel, insulated stimulating needle (B BRAUN contiplex d 
type)
8. Peripheral nerve stimulator
Methods
* Institutional approval
* Patients were advised over night fasting
* All patients were given T.RANITIDINE 150 mg and T.DIAZEPAM 5 mg P.O on 
the night prior to surgery and on the morning of surgery
Intra op
* All patients premedicated with Inj. Fentanyl 1µg/kg and Glycopyrolate i.m 30 mts 
before the procedure
* Monitors-Non invasive BP monitor, ECG, Pulse Oximeter, Urine output
* Base line parameters were recorded
* All patents assigned numbers 1-60
* Group1-all patients with odd numbers
* Group 2 –all patients with even numbers
* An 18 gauge needle was inserted in the fore arm and crystalloid infusion started.
Group 1 
*. Receive a continuous femoral nerve sheath catheter kept in the femoral sheath 
using Winnes Inguinal Perivascular Approach around 9 am . A bolus dose of 30 
ml to distend the femoral sheath to thread the catheter was given during insertion
* At 9.30 am patient receive a spinal sub Arachnoid block using 3.5 cc of 0.5% 
Bupivacaine.
* At 11.30 am continuous peripheral nerve block was initiated with a infusion pump 
at 0.125% Bupivacaine at 10 ml per hour
Group 2
* Receive a continuous epidural catheter kept in the epidural space using loss of 
resistance technique.
* At 9.30 am patient receive a spinal sub Arachnoid block using 3.5 cc of 0.5% 
Bupivacaine.
* At 11.30 am continuous epidural analgesia was initiated with a infusion pump at 
0.125% Bupivacaine at 10 ml per HOUR
Post-operative care 
* All the patients were shifted to ICU
* Patients monitored for pain relief with VAS scores, complication like hypotension, 
Bradycardia, vomiting and urinary retention.
* All patients who develop break through pain (VAS score more than 3) will be 
supplemented with injection Pentazocine 30mg. 
* Patients developing Bradycardia were treated with Inj.atropine and patients who 
had hypotension will be treated with Inj.Ephedrine and I.V. fluids. 
* Patients developing vomiting were treated with Inj.Ondansetron            8.0 mg 
and I.V. fluids. 
* Patients who developed urinary retention were catheterized with Foley catheter of 
appropriate size.  
* Statistical analysis was done with student t test and chi square test as appropriate. 
A P value of less than 0.05 is significant.
OBSERVATION AND RESULTS
AGE DISTRIBUTION
GROUP
1 2 Total
AGE 
GROUP
1
Count 5 1 6
% within GROUP 16.7% 3.3% 10.0%
2
Count 7 5 12
% within GROUP 23.3% 16.7% 20.0%
3
Count 6 11 17
% within GROUP 20.0% 36.7% 28.3%
4
Count 8 8 16
% within GROUP 26.7% 26.7% 26.7%
5
Count 4 5 9
% within GROUP 13.3% 16.7% 15.0%
Total
Count 30 30 60
% within GROUP 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Sig. (2-sided)
Pearson Chi-Square 4.582a 4 .333
Likelihood Ratio 4.850 4 .303
N of Valid Cases 60
CHI SQUARE :  4.582   P=  0.333  statistically not significant.
a. 4 cells (40.0%) have expected count less than 5. 
The minimum expected count is 3.00.
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VAS SCORE ANALYSIS BETWEEN TWO GROUPS
Time Variable Count Mean SD 95% LCL 95% UCL P value
9:30 AM GROUP=1 30 1.733333 0.4497764 1.565384 1.901283 0.779045
Not 
SignificantGROUP=2 30 1.7 0.4660916 1.525959 1.874041
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
11:30am GROUP=1 30 1.766667 0.4301831 1.606034 1.9273 0.325113
Not 
SignificantGROUP=2 30 1.866667 0.3457459 1.737563 1.99577
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VAS SCORE ANALYSIS BETWEEN TWO GROUPS- Contd.
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
12:30 pm GROUP=1 30 1.733333 0.5832923 1.515528 1.951138 1.000000
Not 
SignificantGROUP=2 30 1.733333 0.5832923 1.515528 1.951138
1:30 pm GROUP=1 30 1.633333 0.5560534 1.4257 1.840967 0.818379
Not 
SignificantGROUP=2 30 1.6 0.5632418 1.389682 1.810318
2:30 pm GROUP=1 30 1.866667 0.5713465 1.653322 2.080011 0.825178
Not 
SignificantGROUP=2 30 1.833333 0.5920935 1.612242 2.054425
3:30 pm GROUP=1 30 1.7 0.5959634 1.477464 1.922536 1.000000
Not 
SignificantGROUP=2 30 1.7 0.5349831 1.500234 1.899766
4:30 pm GROUP=1 30 1.866667 0.5713465 1.653322 2.080011 0.656387
Not 
SignificantGROUP=2 30 1.933333 0.5832923 1.715528 2.151138
5:30 pm GROUP=1 30 1.933333 0.4497764 1.765384 2.101283 0.592281
Not 
SignificantGROUP=2 30 1.866667 0.5074162 1.677194 2.056139
6:30 pm GROUP=1 30 1.8 0.5508614 1.594305 2.005695 0.478531
Not 
SignificantGROUP=2 30 1.7 0.5349831 1.500234 1.899766
0.00
3.00
6.00
9.00
12.00
G1 G2
Box Plot
Groups
V
A
S
_
2
_
3
0
VAS SCORE ANALYSIS BETWEEN TWO GROUPS- Contd.
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
7:30 pm GROUP=1 30 1.766667 0.5040069 1.578467 1.954866 1.000000
Not 
SignificantGROUP=2 30 1.766667 0.4301831 1.606034 1.9273
8:30 pm GROUP=1 30 1.733333 0.5832923 1.515528 1.951138 1.000000
Not 
SignificantGROUP=2 30 1.733333 0.5832923 1.515528 1.951138
9:30 pm GROUP=1 30 2.133333 0.5713465 1.919989 2.346678 0.617450
Not 
SignificantGROUP=2 30 2.066667 0.4497764 1.898717 2.234616
10:30 pm GROUP=1 30 1.933333 0.7396799 1.657132 2.209534 0.860076
Not 
SignificantGROUP=2 30 1.966667 0.7183954 1.698413 2.23492
11:30 pm GROUP=1 30 1.933333 0.7396799 1.657132 2.209534 0.859473
Not 
SignificantGROUP=2 30 1.9 0.7119667 1.634147 2.165853
12:30 am GROUP=1 30 2 0.7427813 1.722641 2.277359 0.728848
Not 
SignificantGROUP=2 30 2.066667 0.7396799 1.790466 2.342868
1:30 am GROUP=1 30 1.933333 0.7396799 1.657132 2.209534 1.000000
Not 
SignificantGROUP=2 30 1.933333 0.6914918 1.675126 2.191541
2:30 am GROUP=1 30 2.433333 1.887953 1.72836 3.138307 0.945991
Not 
SignificantGROUP=2 30 2.466667 1.907035 1.754568 3.178765
00.5
1
1.5
2
2.5
3
9:3
0 A
M
1:3
0
4:3
0
7:3
0
10
:30 1:3
0
r4:
30 7:3
0
Time
M
ea
n 
(V
as
 S
co
re
)
Group 1
Group 2
VAS SCORE ANALYSIS BETWEEN TWO GROUPS- Contd.
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
3:30 am GROUP=1 30 2.1 0.7119667 1.834147 2.365853 1.000000
Not 
SignificantGROUP=2 30 2.1 0.7119667 1.834147 2.365853
4:30 am GROUP=1 30 2.033333 0.413841 1.878803 2.187864 0.373879
Not 
SignificantGROUP=2 30 1.933333 0.4497764 1.765384 2.101283
5:30 am GROUP=1 30 1.933333 0.6396838 1.694471 2.172195 0.532224
Not 
SignificantGROUP=2 30 1.833333 0.5920935 1.612242 2.054425
6:30 am GROUP=1 30 1.9 0.4806605 1.720518 2.079482 0.585662
Not 
SignificantGROUP=2 30 1.833333 0.461133 1.661143 2.005523
7:30 am GROUP=1 30 1.966667 0.6686751 1.716979 2.216354 0.850493
Not 
SignificantGROUP=2 30 2 0.6948083 1.740554 2.259446
8:30 am GROUP=1 30 2.266667 0.868345 1.942421 2.590912 0.404422
Not 
SignificantGROUP=2 30 2.466667 0.9732042 2.103266 2.830067
There is no significant difference between the two groups 
BREAK THROUGH PAIN GROUP
GROUP
1 2 Total
BREAK THROUGH 
PAIN
0
Count 2 3 5
% within GROUP 6.7% 10.0% 8.3%
1
Count 28 27 55
% within GROUP 93.3% 90.0% 91.7%
Total
Count 30 30 60
% within GROUP 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Sig. (2-sided)
Pearson Chi-Square .218a 1 .640
Continuity Correctionb .000 1 1.000
Likelihood Ratio .220 1 .639
N of Valid Cases 60
CHI SQUARE :  .218   P=  0.640  statistically not significant.
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 
2.50.
b. Computed only for a 2x2 table 
228
3
27
0
5
10
15
20
25
30
0 1
Break Through Pain
C
ou
nt
Group 1 Group 2
    0 - Break Through Pain, 
    1 - No Break Through Pain
Two patients in Group 1 and 3 patients in Group 2 had break through pain. 
110.00
120.00
130.00
140.00
150.00
G1 G2
Box Plot
Groups
B
_
P
_
S
Y
S
T
O
L
IC
_
9
_
3
0
80.00
92.50
105.00
117.50
130.00
G1 G2
Box Plot
Groups
B_
P_
SY
ST
O
LI
C
_1
1_
30
SYSTOLIC BP ANALYSIS BETWEEN TWO GROUPS 
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
9:30 am GROUP=1 30 124.1333 7.99885 121.1465 127.1202 0.059325
Not 
SignificantGROUP=2 30 127.9333 7.286896 125.2124 130.6543
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
11:30 am GROUP=1 30 114.0667 6.464403 111.6528 116.4805 0.000000
Significant
GROUP=2 30 98.2 10.44328 94.30042 102.0996
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SYSTOLIC BP ANALYSIS BETWEEN TWO GROUPS – Contd.
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
12:30 pm GROUP=1 30 115 8.132523 111.9633 118.0367 0.000429
SignificantGROUP=2 30 106.6667 9.11737 103.2622 110.0712
1:30 pm GROUP=1 30 148.5 181.0582 80.89178 216.1082 0.396215
Not 
SignificantGROUP=2 30 120.2 10.27014 116.3651 124.0349
2:30 pm GROUP=1 30 116.0333 8.984597 112.6784 119.3882 0.000045
SignificantGROUP=2 30 105.4667 9.554683 101.8989 109.0344
3:30 pm GROUP=1 30 117 10.07215 113.239 120.761 0.208660
Not 
SignificantGROUP=2 30 113.4 11.79304 108.9964 117.8036
4:30 pm GROUP=1 30 114.4667 9.376174 110.9655 117.9678 0.016456
SignificantGROUP=2 30 107.4 12.55224 102.7129 112.0871
5:30 pm GROUP=1 30 113.4667 7.682193 110.5981 116.3352 0.035719
SignificantGROUP=2 30 108.8333 8.96 105.4876 112.1791
6:30 pm GROUP=1 30 115.8 8.376486 112.6722 118.9278 0.724314
Not 
SignificantGROUP=2 30 115 9.093386 111.6045 118.3955
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SYSTOLIC BP ANALYSIS BETWEEN TWO GROUPS – Contd.
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
7:30 pm GROUP=1 30 118.2333 9.633574 114.6361 121.8306 0.000184
SignificantGROUP=2 30 109.3333 7.48485 106.5384 112.1282
8:30 pm GROUP=1 30 117.9333 9.996321 114.2006 121.666 0.004327
SignificantGROUP=2 30 110 10.68354 106.0107 113.9893
9:30 pm GROUP=1 30 118.2 9.502812 114.6516 121.7484 0.016235
SignificantGROUP=2 30 111.8 10.49598 107.8807 115.7193
10:30 pm GROUP=1 30 118.3667 7.667591 115.5035 121.2298 0.116277
Not 
SignificantGROUP=2 30 115.0667 8.349823 111.9488 118.1845
11:30 pm GROUP=1 30 115.3 5.614943 113.2033 117.3967 0.015360
SignificantGROUP=2 30 109.3333 11.81855 104.9202 113.7465
12:30 pm GROUP=1 30 115.8667 6.213075 113.5467 118.1867 0.946073
Not 
SignificantGROUP=2 30 116 8.773 112.7241 119.2759
1:30 pm GROUP=1 30 115.5 6.095504 113.2239 117.7761 0.008370
SignificantGROUP=2 30 108 13.7565 102.8632 113.1368
2:30 pm GROUP=1 30 114.8667 5.986959 112.6311 117.1022 0.001146
SignificantGROUP=2 30 121.2 8.180717 118.1453 124.2547
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SYSTOLIC BP ANALYSIS BETWEEN TWO GROUPS – Contd.
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
3:30 pm GROUP=1 30 115.4333 6.420245 113.036 117.8307 0.021774
SignificantGROUP=2 30 112.2667 3.590537 110.9259 113.6074
4:30 pm GROUP=1 30 114.9333 7.234655 112.2319 117.6348 0.385288
Not 
SignificantGROUP=2 30 113.1333 8.641253 109.9066 116.36
5:30 pm GROUP=1 30 117 6.863195 114.4372 119.5628 0.794239
Not 
SignificantGROUP=2 30 116.4333 9.655026 112.8281 120.0386
6:30 pm GROUP=1 30 116.1333 6.532325 113.6941 118.5725 0.009634
SignificantGROUP=2 30 109.2 12.59009 104.4988 113.9012
7:30 pm GROUP=1 30 114.5333 6.724804 112.0222 117.0444 0.838831
Not 
SignificantGROUP=2 30 114.1333 8.353126 111.0142 117.2524
8:30 pm GROUP=1 30 114.5333 8.020376 111.5385 117.5282 0.702656
Not 
SignificantGROUP=2 30 113.7333 8.13224 110.6967 116.77
 There was a significant difference in the BP during the early hours of study 
following which there is no much difference 
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DIASTOLIC BP ANALYSIS BETWEEN TWO GROUPS 
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
9:30 am GROUP=1 30 78.5 5.587856 76.41346 80.58654 0.621686
Not 
SignificantGROUP=2 30 77.76667 5.858582 75.57903 79.9543
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
11:30 am GROUP=1 30 78.56667 6.631603 76.09039 81.04295 0.000000
SignificantGROUP=2 30 63.2 4.505935 61.51746 64.88255
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DIASTOLIC BP ANALYSIS BETWEEN TWO GROUPS – Contd.
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
12:30 pm GROUP=1 30 77.53333 5.399446 75.51714 79.54952 0.000076
SignificantGROUP=2 30 70.2 7.725461 67.31526 73.08473
1:30 pm GROUP=1 30 77.9 6.138348 75.6079 80.19209 0.000092
SignificantGROUP=2 30 70.2 7.93682 67.23634 73.16366
2:30 pm GROUP=1 30 77.76667 5.32841 75.77701 79.75632 0.000217
SignificantGROUP=2 30 70.86667 7.959957 67.89437 73.83897
3:30 pm GROUP=1 30 77.36667 5.991277 75.12949 79.60384 0.001684
SignificantGROUP=2 30 71.16666 8.387525 68.03471 74.29862
4:30 pm GROUP=1 30 79.96667 6.014255 77.72091 82.21243 0.000278
SignificantGROUP=2 30 72.5 8.689074 69.25545 75.74455
5:30 pm GROUP=1 30 79 6.741534 76.48267 81.51733 0.001907
SignificantGROUP=2 30 72.43333 8.763888 69.16084 75.70583
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DIASTOLIC BP ANALYSIS BETWEEN TWO GROUPS – Contd.
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
6:30 pm GROUP=1 30 76.16666
15.1682
1
70.5027
6
81.8305
7
0.393201
Not 
Significan
tGROUP=2 30
73.4333
3
8.53262
8 70.2472
76.6194
7
7:30 pm GROUP=1 30 78.2 6.042379
75.9437
4
80.4562
6 0.011522
Significan
tGROUP=2 30 73.13333
8.75227
4
69.8651
8
76.4014
9
8:30 pm GROUP=1 30 77.56667
7.21914
8
74.8709
9
80.2623
4
0.080182
Not 
Significan
tGROUP=2 30 73.7
9.45096
2
70.1709
5
77.2290
5
9:30 pm GROUP=1 30 78.26667
7.58825
4
75.4331
7
81.1001
7 0.035735
Significan
tGROUP=2 30 73.36667 9.911621 69.6656
77.0677
3
10:30pm GROUP=1 30 78.46667
7.32842
1
75.7301
9
81.2031
4
0.141749
Not 
Significan
tGROUP=2 30 75.3
9.04833
8 71.9213 78.6787
11:30pm GROUP=1 30 78.6 6.95106 76.00443
81.1955
7
0.248656
Not 
Significan
tGROUP=2 30
76.1666
6
9.08231
8
72.7752
8
79.5580
6
12:30am GROUP=1 30 75.26667
14.3501
4
69.9082
3 80.6251
0.948388
Not 
Significan
tGROUP=2 30
75.0666
7
8.83150
1
71.7689
3 78.3644
1:30 am GROUP=1 30 79.33334
5.78543
6
77.1730
2
81.4936
5
0.065916
Not 
Significan
tGROUP=2 30 75.7
8.90234
4
72.3758
1
79.0241
9
2:30 am GROUP=1 30 78.4 5.288895
76.4250
9
80.3749
1
0.089888
Not 
Significan
tGROUP=2 30
75.1333
3
8.92394
4
71.8010
8
78.4655
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DIASTOLIC BP ANALYSIS BETWEEN TWO GROUPS – Contd.
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
3:30 am GROUP=1 30 78.76667
5.59361
3
76.6779
8
80.8553
5
0.090921
Not 
Significan
tGROUP=2 30 75.3
9.52365
5
71.7438
1
78.8561
9
4:30 am GROUP=1 30 78.46667
6.04428
1
76.2096
9
80.7236
4
0.188517
Not 
Significan
tGROUP=2 30 76.1
7.63995
8
73.2471
9 78.9528
5:30 am GROUP=1 30 79.33334
6.01912
6
77.0857
5
81.5809
1
0.143983
Not 
Significan
tGROUP=2 30 76.3
9.46554
6
72.7655
1 79.8345
6:30 am GROUP=1 30 77.8 6.477548
75.3812
4
80.2187
6
0.460708
Not 
Significan
tGROUP=2 30 76.4
8.04127
3
73.3973
4
79.4026
6
7:30 am GROUP=1 30 79 5.349831
77.0023
4
80.9976
6
0.252360
Not 
Significan
tGROUP=2 30
76.9666
7
8.01069
6
73.9754
3
79.9579
1
8:30 am GROUP=1 30 78.66666
6.50375
7
76.2381
2
81.1001
7 0.035735
Significan
tGROUP=2 30 77.26667
7.17242
5
74.5884
4
77.0677
3
There was a significant  difference in the diastolic BP between the two groups 
based on the p value
HYPO TENSION  GROUP
Crosstab
GROUP
1 2 Total
HYPO TENSION
0
Count 30 20 50
% within GROUP 100.0% 66.7% 83.3%
1
Count 0 10 10
% within GROUP .0% 33.3% 16.7%
Total
Count 30 30 60
% within GROUP 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Sig. (2-sided)
Pearson Chi-Square 12.000a 1 .001
Continuity Correctionb 9.720 1 .002
Likelihood Ratio 15.876 1 .000
N of Valid Cases 60
CHI SQUARE :  12.000   P=  0.001 statistically significant.
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Hypo Tension
C
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nt
Group 1 Group 2
     0-No hypotension, 1-Hypotension
 It is evident that none of the patients in group one developed hypotension where 
as 10 patients in group 2 developed hypotension .There was a significant increase in the 
incidence of hypotension in group 2.
70.00
76.25
82.50
88.75
95.00
G1 G2
Box Plot
Groups
PR
_9
_3
0
50.00
62.50
75.00
87.50
100.00
G1 G2
Box Plot
Groups
PR
11
_3
0
PULSE RATE ANALYSIS BETWEEN TWO GROUPS 
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
9:30 
am GROUP=1 30
81.8333
4
5.25280
4 79.8719
83.7947
6
0.654728
Not 
Significan
tGROUP=2 30
81.1333
3
6.71967
4 78.62417 83.6425
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
11:30am GROUP=1 30 82.93333
4.12672
8
81.3923
9
84.4742
8 0.000000
Significan
tGROUP=2 30 65.4 9.704602
61.7762
4
69.0237
6
60.00
68.75
77.50
86.25
95.00
G1 G2
Box Plot
Groups
P
R
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PULSE RATE ANALYSIS BETWEEN TWO GROUPS – Contd.
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
12:30 pm GROUP=1 30 83.66666
5.17509
5
81.7342
5
85.5990
8 0.000000
Significan
tGROUP=2 30 67.86667
6.32310
1
65.5055
8
70.2277
5
1:30 pm GROUP=1 30 82.4 4.499808
80.7197
4
84.0802
5 0.000000
Significan
tGROUP=2 30 67.8 6.50411 65.37132
70.2286
8
2:30 pm GROUP=1 30 82.13333
4.57680
3
80.4243
2
83.8423
4 0.000000
Significan
tGROUP=2 30 69.33334
7.54450
4
66.5161
7 72.1505
3:30 pm GROUP=1 30 82.2 3.497782
80.8939
1 83.5061 0.000000
Significan
tGROUP=2 30 70.23333
7.54610
3
67.4155
7
73.0510
9
4:30 pm GROUP=1 30 82.26667
4.09316
8
80.7382
5
83.7950
8 0.000000
Significan
tGROUP=2 30 70.6 8.467381
67.4382
2
73.7617
7
5:30 pm GROUP=1 30 82.13333
4.19961
7
80.5651
7
83.7014
9 0.000000
Significan
tGROUP=2 30 71.86667
8.64524
4
68.6384
8
75.0948
6
6:30 pm GROUP=1 30 82.53333
4.09990
2 81.0024
84.0642
6 0.000000
Significan
tGROUP=2 30 72.33334
8.59965
2
69.1221
7
75.5444
9
7:30 pm GROUP=1 30 82.66666
4.04571
6
81.1559
8
84.1773
6 0.000001
Significan
tGROUP=2 30 71.76667
9.81794
1
68.1005
9
75.4327
5
8:30 pm GROUP=1 30 83.03333
3.30603
8
81.7988
4
84.2678
3 0.000000
Significan
tGROUP=2 30 72.33334
9.33784
8
68.8465
3
75.8201
4
9:30 pm GROUP=1 30 83.13333
4.47778
7 81.4613
84.8053
7 0.000002
Significan
tGROUP=2 30 72.86667
9.65163
3
69.2626
9
76.4706
4
PULSE RATE ANALYSIS BETWEEN TWO GROUPS – Contd.
Time Variable Count Mean SD 95% LCL
95% 
UCL P value
10:30 
pm GROUP=1 30
83.1333
3
4.19139
8
81.5682
4
84.6984
3 0.000000
Significan
tGROUP=2 30 73.16666
8.66257
7
69.9320
1
76.4013
3
11:30 
pm GROUP=1 30 82.6
4.20672
7
81.0291
8
84.1708
1 0.000001
Significan
tGROUP=2 30 72.6 9.174929
69.1740
3
76.0259
8
12:30 
am GROUP=1 30
81.9333
3
3.80501
8
80.5125
2
83.3541
5 0.000000
Significan
tGROUP=2 30 71.13333
8.89297
8
67.8126
4
74.4540
3
1:30 am GROUP=1 30 81.9 4.138549
80.3546
4
83.4453
6 0.000000
Significan
tGROUP=2 30 72.23333
7.22333
3
69.1765
8
75.2900
8
2.30 am GROUP=1 30 83.13333
3.98906
5
81.6437
9
84.6228
7 0.000001
Significan
tGROUP=2 30 73.6 8.857492
70.2925
6
76.9074
4
3.30 am GROUP=1 30 83.6 3.765543
82.1939
2
85.0060
7 0.000001
Significan
tGROUP=2 30 73.63333
8.99993
6
70.2727
1
76.9939
7
4:30 am GROUP=1 30 83.4 3.93569 81.93039
84.8696
1 0.000001
Significan
tGROUP=2 30 73.8 8.965066
70.4523
9
77.1476
1
5:30 am GROUP=1 30 83.2 4.318365
81.5874
9
84.8125
1 0.000014
Significan
tGROUP=2 30 74.06667
9.63446
9
70.4690
9
77.6642
4
6:30 am GROUP=1 30 82.6 4.239388
81.0169
8
84.1830
1 0.000008
Significan
tGROUP=2 30 73.06667
9.76599
8
69.4199
8
76.7133
5
7:30 am GROUP=1 30 82.16666 4.60946
80.4454
7
83.8878
7 0.000126
Significan
tGROUP=2 30 74.33334
9.36734
4
70.8355
1 77.83115
8:30 am GROUP=1 30 82.6 4.206727
81.0291
8
84.1708
1
0.000037
Significan
tGROUP=2 30 74.46667 9.03149
71.0942
5
77.8390
8
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There  is  a  significant  difference  in  the  pulse  rate  between  the  two  groups 
compared over a period of 24 hours. 
BRADYCARDIA GROUP
Crosstab
GROUP
1 2 Total
BRADYCARDIA
0
Count 30 20 50
% within GROUP 100.0% 66.7% 83.3%
1
Count 0 10 10
% within GROUP .0% 33.3% 16.7%
Total
Count 30 30 60
% within GROUP 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Sig. (2-sided)
Pearson Chi-Square 12.000a 1 .001
Continuity Correctionb 9.720 1 .002
Likelihood Ratio 15.876 1 .000
N of Valid Cases 60
CHI SQUARE :  12.000   P=  0.001 statistically significant.
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 
5.00.
b. Computed only for a 2x2 table 
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Bradycardia
C
ou
nt
Group 1 Group 2
      0-No Bradycardia, 1- Bradycardia
 Bradycardia Occurred More Frequently In Group 2. Around ten patients in group 
2  developed  Bradycardia  where  as  none  of  the  patients  in  group  1  developed 
hypotension.
COMPARISON OF VOMITING IN GROUPS  
GROUP
1 2 Total
VOMITTING
0
Count 30 25 55
% within GROUP 100.0% 80.0% 90.0%
1
Count 0 5 5
% within GROUP .0% 16.7% 8.3%
Total
Count 30 30 60
% within GROUP 100.0% 100.0% 100.0%
30
0
25
5
0
5
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35
0 1
Vomitting
C
ou
nt
Group 1 Group 2
Chi-Square Tests
Value df Asymp. Sig. (2-sided)
Pearson Chi-Square 6.667a 2 .036
Likelihood Ratio 8.986 2 .011
N of Valid Cases 60
CHI SQUARE :  6.667  P=  0.036 statistically significant.
 
     0-No Vomiting, 
     1- Vomiting occurred  
Vomiting is significantly higher in group 2
COMPARISON OF URINARY RETENTION IN GROUPS
GROUP
1 2 Total
URINARY 
RETENTION 
0
Count 30 25 55
% within GROUP 54.50% 45.50% 100.00%
1
Count 0 5 5
% within GROUP 0.00% 100.00% 100.00%
Total
Count 30 30 60
% within GROUP 100.0% 100.0% 100.0%
CHI SQUARE :  5.455  P =  0.01952 statistically significant.
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Urinary Retention
C
ou
nt
Group 1 Group 2
        0 - No Urinary Retention, 1- Urinary Retention
Significant difference in urinary retention between the two groups is seen.
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Patient Acceptance
C
ou
nt
Group 1 Group 2
COMPARISON OF PATIENT ACCEPTANCE IN GROUPS
GROUP
1 2 Total
PATIENT 
ACCEPTANCE
1
Count 18 3 21
% within GROUP 60.0% 10.0% 35.0%
2
Count 10 15 25
% within GROUP 33.3% 46.7% 40.0%
3
Count 2 12 14
% within GROUP 6.7% 40.0% 23.3%
Total
Count 30 30 60
% within GROUP 100.0% 100.0% 100.0%
Chi-Square Tests
Value Df Asymp. Sig. (2-sided)
Pearson Chi-Square 19.524 3 .000
Likelihood Ratio 21.868 3 .000
N of Valid Cases 60
CHI SQUARE :  19.524   P=  0.000 statistically significant.
          1 - Very satisfying, 
2 -  Satisfying, 
3 -  Not satisfying
Patient acceptance is high with group 1as evident from the chisquare analysis.
DISSCUSSION
 The  aim  of  postoperative  pain  treatment is  to  provide  subjective  comfort  in 
addition to inhibiting trauma-induced nociceptive impulses in order to blunt autonomic 
and somatic reflex responses to pain and subsequently to enhance restoration of function 
by allowing the patient to breathe, cough and move more easily2.
 Unrelieved pain after surgery is often unhealthy; fortunately, it is preventable or 
controllable in an overwhelming majority of cases7.
 Pain control may have a further benefit of improving clinical outcome by reducing 
the incidence of postoperative complications such as:
* myocardial infarction or ischemia 
* risk of tachycardia and dysrhythmia 
* impaired wound healing 
* risk of atelectasis 
* thromboembolic events 
* peripheral vasoconstriction 
* metabolic acidosis. 
 Direct injection of local analgesic drugs close to peripheral nerves, major nerve 
trunks or nerve roots produces analgesia by blocking conduction of afferent impulses.
 Epidural  analgesia  is  a  useful  technique  for  the  relief  of  postoperative  pain 
because a catheter can be used to maintain analgesia in the postoperative period." 
There  are  numerous  studies  to  compare  peripheral  nerve  block  with  epidural 
analgesia for post of pain relief, the results of which were conflicting.  In some of the 
studies, peripheral nerve block was the preferred technique whereas in some studies it is 
not8, 14. 
 I  was  Impressed  by  the  Article  in  Acta  Analgesia  by  Syngelyn  who  did  a 
Randomised control study in 1300 Patients comparing continuous Femoral 3-in-1 Nerve 
Block  with  Epidural  for  post  Operative  pain  relief  in  patients  undergoing  total  hip 
replacement.
The study was done in 1338 patients of ASA physical status I, II and III patients 
scheduled for elective unilateral total hip Arthroplasty (THA).  The post operative pain 
relief was given for a period of 48 hours. During the study the pain scores supplemental 
analgesia satisfaction score and side effects like vomiting, nausea, pruritus, hypotension, 
urinary retention were compared between the two groups. Post operative pain relief was 
coparable in both the groups. In the study, continuous femoral analgesia was associated 
with a significantly less frequent incidence of nausea, vomiting, urinary retention and 
hypotension when compared with a continuous epidural analgesia. The incident of side 
effects was 23.5% in continuous femoral group whereas it was 71.9% with continuous 
epidural. The satisfaction score was significantly higher in continuous femoral group. 
(About 87± 14) in compared with continuous epidural group (about 81 or ± 14). 
 Our aim is to compare the efficacy of continuous femoral 3 in 1 nerve block to 
epidural analgesia for post-operative pain relief in NECK OF FEMUR fractures
 In our study .all the patients were males to avoid the sexual disparity, in the pain 
perception based on David Sheffield, et. al25.
 It is evident from the statistics that there is no significant difference in the age 
distribution between the two groups.
PAIN
The surgery for fracture neck of femur includes Hemi arthroplasty and DHS.   The 
site of skin incision is in the junction of medial and lateral thigh about 2cm from the 
ASIS.  The cutaneous distribution  of  this  area is  covered by the  femoral  and lateral 
cutaneous nerve of the thigh. The Fasia lata and the Vastus muscles which are retracted 
during the procedure were supplied by the femoral nerve. A small part of the posterior 
acetabulam is alone supplied by the nerve to quadratus femoris.
The Femoral nerve block provided effective post operative analgesia in patents 
with fracture neck of femur31, femoral shaft fracture32, Trocantric fracture and total hip 
replacement8.
In the earlier studies by Singelyn et.al., the pain relief was comparable8 in both a 
groups but Cuvillon et.al.,  in his study showed that  Continuous femoral  nerve block 
provided limited pain relief after hip fracture did not reduced side effects and induced an 
expensive cost11. 
 In our study we did not notice any significant difference in the pain level between 
the two groups as evident in the VAS scores. How ever 2 patients in group 1 and 3 
patients in group 2 developed break through pain defined as VAS scale 3 and above 
according to universal pain measurement tool.  The pain relief was comparable through 
out the 24 hour period of study as evident from the p value 7. 
 The  patients  in  both  the  groups  who  developed  break  through  pain  were 
supplemented with Inj.Pentazocine 30mg I.V.
HYPOTENSION AND BRADYCARDIA26, 28 
 The  sympathectomy  produced  by  central  neuraxial  anesthesia  induces 
hemodynamic changes. Hypotension and bradycardia are the most common side effects 
seen with sympathetic denervation.  Risk factors associated with hypotension include 
hypovolemia, preoperative hypertension, high sensory block height, age older than 40 
years, obesity, combined general and spinal anesthesia, history of hypertension, elevated 
BMI,  high  level  of  sensory  block  height,  and  urgency  of  surgery  all  increase  the 
likelihood of hypotension after central neuraxial anesthesia. 
The  cause  hypotension  includes  paralysis  of  the  sympathetic  vasoconstrictor 
fibers, loss of the milking action of peripheral muscles of lower limb and blockade of 
cardio accelerator fibers in higher block. The causes of bradycardia include blockade of 
cardio accelerator  fibers  in higher block,  the presence of  Bezold Jarisch Reflex and 
Bainbridge reflex.  
 The Bezold–Jarisch reflex (BJR) has been implicated as a cause of bradycardia, 
hypotension after central neuraxial anesthesia, The BJR is a cardio-inhibitory reflex and 
consists  of  the  triad  of  symptoms,  bradycardia,  hypotension  and  cardiovascular 
collapse27.
 There was a significant fall in the BP in Group 2 compared to Group 1 during 
most of the hours of monitoring as evident from the p value. None of the patients in 
Group 1 had a fall in BP.
 The fall in BP was more pronounced at the beginning of the epidural analgesia as 
evident from the study. Although most have a fall  of more than 20% in systolic BP 
which is the range in which the BP is maintained during anesthesia, ten patients out of 
30 patients had a fall in BP of systolic less than 90 requiring ephedrine 6 mg increments, 
of  the ten patients  3  patients  had more than one episode requiring  more ephedrine 
supplements.
 Bradycardia  and  asystole  can  occur  unexpectedly  during  neuraxial  anesthesia. 
Moderate  or  severe  bradycardia  may  occur  at  any time during neuraxial  anesthesia, 
regardless of the duration of anesthesia. Low baseline heart rate increases the risk for 
bradycardia. 
 The incidence of Brady cardia is more pronounced in group 2, where as none of 
the patients in group 1 developed Brady cardia. The patients who developed Bradycardia 
were treated with Inj. Atropine 0.6mg. I.V.
VOMITING
      It  is  a  common  complication  associated  with  hypotension  during  anesthesia. 
Hypotension is a common occurrence during neuraxial anesthesia. Low blood pressure 
may lead to brain stem ischemia, which is thought to activate the circulatory, respiratory, 
and vomiting centers grouped together in the medulla. Hypotension also leads to gut 
ischemia and the release of emetogenic substances (e.g., serotonin) from the intestines. 
Neuraxial anesthesia also changes the function of the gastrointestinal tract. Sympathetic 
blockade  by  local  anesthetics  creates  unopposed  vagal  action,  resulting  in 
gastrointestinal hyperactivity. Lanz et.al.,  in their study showed that the incidence of 
vomiting during epidural anesthesia  was 29% in orthopedic procedures29. 
There was a significant difference in the incidence of vomiting between the two 
groups  as  evident  from  the  p  value.  Five  patients  out  of  group  2  who  developed 
hypotension had vomiting (incidence 16%). The vomiting occurred during the episode 
of hypotension. None of the patients in group 1 had vomiting. 
URINARY RETENTION
 Urinary retention is common after anesthesia and surgery, reported incidence of 
between 5% and 70%.   In the study by Syngelyn, the incidence of urinary retention was 
13% after continuous femoral nerve block. In the study by Capdevila et al., no patient 
developed  urinary  retention  after  continuous  femoral  nerve  block.   In  our  study,  5 
patients belonging to Group 2 had urinary retention, requiring catheterization. None of 
the patients in Group I developed urinary retention30. 
PATIENT ACCEPTANCE
 Patient acceptance was more with group 1 compared with group 2, and it was 
found to clinically significant from the p value, The most common reason found for the 
decreased acceptance in group was that most patients don’t like to have a catheter at the 
back even though the pain relief was good. Also the Group 1 patients due to their early 
femoral nerve block could be easily positioned for spinal anesthesia than Group 28.
SUMMARY
There is no significant difference in the age distribution between the two groups.
In our study we did not notice any significant difference in the pain level between 
the two groups as evident in the VAS scores.
Only 2 patients in Group 1 and 3 patients in Group 2 developed break through 
pain requiring supplementation with opioids.
 There was a significant fall in the BP in Group 2 compared to Group 1 during 
most of the hours of monitoring as evident from the p value. The difference was more in 
the early hours of the study.
 There was a significant difference in the incidence of vomiting between the two 
groups  as  evident  from the  p  value.  The  vomiting  occurred  during  the  episode  of 
hypotension where as none of the patients in group 1 had vomiting.
 The incidence of Bradycardia is more pronounced in group 2, where as none of 
the patients in group 1 developed brady cardia.
 5 patients belonging to Group 2 have urinary retention, requiring catheterization. 
The difference between the groups was statistically significant.
 Patient acceptance was more with group 1 compared with group 2, and the most 
common reason found for  the decreased acceptance in group was that  most  patients 
don’t like to have a catheter at  the back even though the pain relief was good, and 
peripheral nerve block enabled better pain free patient positioning. 
CONCLUSION
 THE  FEMORAL  NERVE  BLOCK  WHEN  COMPARED  TO  EPIDURAL 
ANALGESIA OFFERED COMPARABLE PAIN RELIEF WITH LOW INCIDENCE 
OF COMPLICATIONS, WITH INCREASED PATIENT ACCEPTANCE
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A comparative study of continuous femoral 3 in 1 nerve block vs 
continuous epidural nerve block for post op analgesia
Date of admission Date of Surgery
Name  Age/ sex Ip no
Pre op  ASA STATUS  
 Nature of injury    
 Procedure Done   
BP- HR- CVS RS
INCISION SITE    
POSITION  Length of incision  
Plan of anesthesia   
Time of block 
(SAB)    
Plan of post op pain relief Nerve block /epidural 
Length of catheter kept inside   
Amount of bolus drug injected   
Duration of surgery   
INFUSION
TIME BP HR VAS SCORE U/O
OTHER 
COMPLICATIONS
9:30AM
11:30AM
12:30AM
1:30PM
2:30PM
3:30PM
4:30PM
5:30 PM
6:30 PM
7:30PM
8:30PM
9:30PM
10:30 PM
11:30 PM
12:30PM
1:30AM
2:30AM
3:30AM
4:30 AM
5:30 AM
6:30 AM
7 :30 AM
8:30 AM
BREAK THROUGH PAIN
Time
Alternate mode of pain relief
Remarks : patient satisfaction in own words
ABBREVIATIONS 
ASIS Anterior Superior Iliac Spine 
BJR Bezold–Jarisch reflex
BMI Body Mass Index
DHS Dynamic Hip Screw
NOF Neck of Femur 
PONV Post Operative Nausea and Vomiting  
PVR Peripheral Vascular Resistance 
THR Total Hip Replacement
VAS Visual Analogue Scale
BP Blood Pressure
HR Heart Rate
SAB Sub Arachnoid Block 
U/O Urine Output
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Contiplex d peripheral nerve sheath catheter

